# Pilot Study of NKG2D-Ligand Targeted CAR-NK Cells in Patients With Metastatic Solid Tumours

> **NCT03415100** · PHASE1 · UNKNOWN · sponsor: **The Third Affiliated Hospital of Guangzhou Medical University** · enrollment: 30 (estimated)

## Conditions studied

- Solid Tumours

## Interventions

- **BIOLOGICAL:** CAR-NK cells targeting NKG2D ligands

## Key facts

- **NCT ID:** NCT03415100
- **Lead sponsor:** The Third Affiliated Hospital of Guangzhou Medical University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-01-02
- **Primary completion:** 2019-12
- **Final completion:** 2019-12
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2018-08-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03415100

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03415100, "Pilot Study of NKG2D-Ligand Targeted CAR-NK Cells in Patients With Metastatic Solid Tumours". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT03415100. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*